Product Information

CLINDACIN 1% FOAM is a generic product labeled by Medimetriks Pharmaceuticals Inc., priced at $1.9087 per GM under NDC 43538017910. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Mar 31, 2010. Its Orange Book therapeutic-equivalence code is AT.

The High Outlier badge above means this manufacturer's average price in the clindamycin phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CLINDACIN 1% FOAM

clindamycin phosphate
$1.9087per GM
High Outlier

Strength

10 mg/g

NDC

43538017910

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

CLINDAMYCIN PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090785

FDA Approved

3/31/2010

TE Code

AT

On Market Since

3/21/2010

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDACIN 1% FOAM has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 50.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9087 per GM
All-time high$3.8476 (May 15, 2024)
All-time low$1.9087 (Aug 19, 2026)
52-week high$3.4789
52-week low$1.9087
Median price$2.6579
Average price$2.8160
Largest weekly change-13.8% (Jun 19, 2024)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

-4.9%

1M

-4.9%

3M

-17.2%

6M

-30.6%

1Y

-44.8%

3Y

N/A

5Y

N/A

All

-50.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CLINDACIN 1% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for CLINDACIN 1% FOAM, manufactured by Medimetriks Pharmaceuticals Inc., is $1.9087 per GM (NDC 43538017910), effective Aug 19, 2026.

How has the price of CLINDACIN 1% FOAM changed over time?

Over the history we have for it, the NADAC for CLINDACIN 1% FOAM has declined 50.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for CLINDACIN 1% FOAM?

Since Apr 17, 2024, the NADAC for CLINDACIN 1% FOAM has ranged from a low of $1.9087 (Aug 19, 2026) to a high of $3.8476 (May 15, 2024), with a median of $2.6579 per GM.

Are there cheaper alternatives to CLINDACIN 1% FOAM?

No other NADAC-published product currently shares the active ingredient and strength of CLINDACIN 1% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLINDACIN 1% FOAM?

CLINDACIN 1% FOAM (NDC 43538017910) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a generic product.